Swiss National Bank’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-73,300
| Closed | -$460K | – | 2387 |
|
|
2025
Q1 | $460K | Hold |
73,300
| – | – | ﹤0.01% | 2354 |
|
|
2024
Q4 | $595K | Hold |
73,300
| – | – | ﹤0.01% | 2371 |
|
|
2024
Q3 | $1.33M | Buy |
73,300
+17,300
| +31% | +$313K | ﹤0.01% | 2087 |
|
|
2024
Q2 | $577K | Hold |
56,000
| – | – | ﹤0.01% | 2385 |
|
|
2024
Q1 | $595K | Hold |
56,000
| – | – | ﹤0.01% | 2415 |
|
|
2023
Q4 | $511K | Sell |
56,000
-4,200
| -7% | -$38.3K | ﹤0.01% | 2470 |
|
|
2023
Q3 | $624K | Sell |
60,200
-11,300
| -16% | -$117K | ﹤0.01% | 2453 |
|
|
2023
Q2 | $1.02M | Buy |
71,500
+31,100
| +77% | +$445K | ﹤0.01% | 2280 |
|
|
2023
Q1 | $288K | Sell |
40,400
-1,100
| -3% | -$7.85K | ﹤0.01% | 2612 |
|
|
2022
Q4 | $466K | Hold |
41,500
| – | – | ﹤0.01% | 2586 |
|
|
2022
Q3 | $460K | Hold |
41,500
| – | – | ﹤0.01% | 2598 |
|
|
2022
Q2 | $350K | Buy |
41,500
+8,100
| +24% | +$68.3K | ﹤0.01% | 2689 |
|
|
2022
Q1 | $455K | Buy |
33,400
+2,400
| +8% | +$32.7K | ﹤0.01% | 2615 |
|
|
2021
Q4 | $610K | Hold |
31,000
| – | – | ﹤0.01% | 2627 |
|
|
2021
Q3 | $995K | Hold |
31,000
| – | – | ﹤0.01% | 2441 |
|
|
2021
Q2 | $1.05M | Buy |
31,000
+14,400
| +87% | +$487K | ﹤0.01% | 2463 |
|
|
2021
Q1 | $623K | Buy |
16,600
+500
| +3% | +$18.8K | ﹤0.01% | 2438 |
|
|
2020
Q4 | $535K | Hold |
16,100
| – | – | ﹤0.01% | 2451 |
|
|
2020
Q3 | $590K | Hold |
16,100
| – | – | ﹤0.01% | 2325 |
|
|
2020
Q2 | $530K | Buy |
+16,100
| New | +$530K | ﹤0.01% | 2370 |
|